| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand S Rerks-Ngarm, P Pitisuttithum, S Nitayaphan, J Kaewkungwal, J Chiu, ... New England Journal of Medicine 361 (23), 2209-2220, 2009 | 3716 | 2009 |
| Immune-correlates analysis of an HIV-1 vaccine efficacy trial BF Haynes, PB Gilbert, MJ McElrath, S Zolla-Pazner, GD Tomaras, ... New England Journal of Medicine 366 (14), 1275-1286, 2012 | 2078 | 2012 |
| Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys JB Whitney, AL Hill, S Sanisetty, P Penaloza-MacMaster, J Liu, M Shetty, ... Nature 512 (7512), 74-77, 2014 | 717 | 2014 |
| Looking beyond COVID-19 vaccine phase 3 trials JH Kim, F Marks, JD Clemens Nature medicine 27 (2), 205-211, 2021 | 694 | 2021 |
| Central nervous system viral invasion and inflammation during acute HIV infection V Valcour, T Chalermchai, N Sailasuta, M Marovich, S Lerdlum, ... The Journal of infectious diseases 206 (2), 275-282, 2012 | 569 | 2012 |
| Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys DH Barouch, J Liu, H Li, LF Maxfield, P Abbink, DM Lynch, MJ Iampietro, ... Nature 482 (7383), 89-93, 2012 | 521 | 2012 |
| Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 M Rolland, PT Edlefsen, BB Larsen, S Tovanabutra, E Sanders-Buell, ... Nature 490 (7420), 417-420, 2012 | 488 | 2012 |
| Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination NL Yates, HX Liao, Y Fong, A DeCamp, NA Vandergrift, WT Williams, ... Science translational medicine 6 (228), 228ra39-228ra39, 2014 | 467 | 2014 |
| Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG GD Tomaras, G Ferrari, X Shen, SM Alam, HX Liao, J Pollara, ... Proceedings of the National Academy of Sciences 110 (22), 9019-9024, 2013 | 446 | 2013 |
| Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family M Bonsignori, J Pollara, MA Moody, MD Alpert, X Chen, KK Hwang, ... Journal of virology 86 (21), 11521-11532, 2012 | 440 | 2012 |
| Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2 HX Liao, M Bonsignori, SM Alam, JS McLellan, GD Tomaras, MA Moody, ... Immunity 38 (1), 176-186, 2013 | 438 | 2013 |
| Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines AW Chung, M Ghebremichael, H Robinson, E Brown, I Choi, S Lane, ... Science translational medicine 6 (228), 228ra38-228ra38, 2014 | 432 | 2014 |
| Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials DC Montefiori, C Karnasuta, Y Huang, H Ahmed, P Gilbert, MS De Souza, ... The Journal of infectious diseases 206 (3), 431-441, 2012 | 358 | 2012 |
| Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys DH Barouch, KE Stephenson, EN Borducchi, K Smith, K Stanley, ... Cell 155 (3), 531-539, 2013 | 356 | 2013 |
| Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology AW Chung, MP Kumar, KB Arnold, WH Yu, MK Schoen, LJ Dunphy, ... Cell 163 (4), 988-998, 2015 | 355 | 2015 |
| Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection J Ananworanich, A Schuetz, C Vandergeeten, I Sereti, M De Souza, ... PloS one 7 (3), e33948, 2012 | 348 | 2012 |
| Prospective study of acute HIV-1 infection in adults in East Africa and Thailand ML Robb, LA Eller, H Kibuuka, K Rono, L Maganga, S Nitayaphan, ... New England Journal of Medicine 374 (22), 2120-2130, 2016 | 313 | 2016 |
| Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection DJ Colby, L Trautmann, S Pinyakorn, L Leyre, A Pagliuzza, E Kroon, ... Nature medicine 24 (7), 923-926, 2018 | 311 | 2018 |
| Vaccine development for emerging infectious diseases JL Excler, M Saville, S Berkley, JH Kim Nature medicine 27 (4), 591-600, 2021 | 304 | 2021 |
| Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection S Zolla-Pazner, A DeCamp, PB Gilbert, C Williams, NL Yates, ... PloS one 9 (2), e87572, 2014 | 291 | 2014 |
